View Older Stories View More Recent Stories
-
Canadian dollar to gain but needs NAFTA deal to score home run: Reuters Poll
-
Nevsun's Board of Directors Rejects Lundin Mining's Hostile Bid; Offer Does Not Recognize the Value of Nevsun's Assets; Company to Proceed with Full Strategic Review
-
Affimed Therapeutics (AFMD) PT Lowered to $4 at BMO Capital
-
ObsEva (OBSV) PT Lowered to $30 at BMO Capital
-
Conduent (CNDT) PT Raised to $23 at BMO Capital
-
Mylan (MYL) PT Lowered to $47 at BMO Capital
-
Carvana (CVNA) PT Raised to $48 at BMO Capital
-
Horizon Pharma (HZNP) PT Raised to $19 at BMO Capital
-
GrafTech International Ltd. (EAF) Prices 23M Share Upsized Common Offering at $20/Sh; Announces Concurrent 11.68M Share Buyback from Brookfield Asset Management (BAM)
-
Central Garden & Pet Company (CENT) Prices 5M Class A Share Offering at $37/Sh
-
BMO Capital Downgrades RPC Inc. (RES) to Market Perform
-
GrafTech Announces the Pricing of Secondary Offering and Concurrent Share Buyback
-
Central Garden & Pet Prices Public Offering of Class A Common Stock
-
Trevali Reports Q2-2018 Financial Results
-
Match Group (MTCH) PT Raised to $52 at BMO Capital
-
North American Financial 15 Split Corp. Announces Overnight Offering
-
Core-Mark Holding (CORE) PT Raised to $30 at BMO Capital
-
Regal Beloit (RBC) PT Raised to $92 at BMO Capital
-
TriMas Corp. (TRS) PT Raised to $34 at BMO Capital
-
Kennametal (KMT) PT Raised to $46 at BMO Capital
-
Alder Biopharm (ALDR) PT Raised to $23 at BMO Capital
-
Halozyme Therapeutics (HALO) PT Raised to $21 at BMO Capital
-
Nobul Corporation Announces Growth Round of Funding Led by BMO Capital Markets and GMP Securities L.P.
-
Walt Disney (DIS) PT Raised to $110 at BMO Capital
-
Jazz Pharmaceuticals (JAZZ) PT Raised to $206 at BMO Capital
-
Halozyme Therapeutics (HALO) PT Raised to $21 at BMO Capital
-
Alder Biopharm (ALDR) PT Raised to $23 at BMO Capital
-
Newell Rubbermaid (NWL) PT Lowered to $25 at BMO Capital
-
Physicians Realty Trust Announces Amendment and Extension of Credit Agreement
-
BMO Capital Downgrades Spark Therapeutics (ONCE) to Market Perform
-
Mallinckrodt plc (MNK) PT Raised to $37 at BMO Capital
-
TRONOX (TROX) PT Lowered to $28 at BMO Capital
-
LyondellBasell Industries (LYB) PT Raised to $112 at BMO Capital
-
Sally Beauty Holdings (SBH) PT Lowered to $14 at BMO Capital
-
Venator Materials (VNTR) PT Lowered to $17 at BMO Capital
-
Akcea Therapeutics, Inc. (AKCA) PT Raised to $40 at BMO Capital
-
Tyson (TSN) PT Lowered to $82 at BMO Capital
-
Intercontinental Exchange Prices $2,250,000,000 in Senior Notes and Issues Notice of Redemption of 2.50% Senior Notes Due 2018
-
GrafTech International Ltd. (EAF) Announces Launch of 20M Secondary Offering and Concurrent Share Buyback
-
GrafTech Announces the Launch of a Secondary Offering and Concurrent Share Buyback
-
Central Garden & Pet Company (CENT) Announces $200M Public Offering of Class A Common Stock
-
Central Garden & Pet Announces Public Offering of Class A Common Stock
-
Take-Two Interactive (TTWO) PT Raised to $119 at BMO Capital
-
Nevro Corp (NVRO) PT Lowered to $76 at BMO Capital
-
GrafTech (EAF) PT Raised to $28 at BMO Capital
-
Intrepid Potash (IPI) PT Lowered to $3.25 at BMO Capital
-
Chemours (CC) PT Lowered to $68 at BMO Capital
-
Athene Holding (ATH) PT Raised to $62 at BMO Capital
-
Stericycle (SRCL) PT Lowered to $63 at BMO Capital
-
Bright Horizons (BFAM) PT Raised to $118 at BMO Capital
